<VariationArchive RecordType="classified" VariationID="2766" VariationName="NM_024312.5(GNPTAB):c.3474_3475del (p.His1158fs)" VariationType="Deletion" Accession="VCV000002766" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2013-10-01" MostRecentSubmission="2015-04-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17805" VariationID="2766">
      <GeneList>
        <Gene Symbol="GNPTAB" FullName="N-acetylglucosamine-1-phosphate transferase subunits alpha and beta" GeneID="79158" HGNC_ID="HGNC:29670" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="101745499" stop="101830959" display_start="101745499" display_stop="101830959" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="102139274" stop="102224644" display_start="102139274" display_stop="102224644" Strand="-" />
          </Location>
          <OMIM>607840</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024312.5(GNPTAB):c.3474_3475del (p.His1158fs)</Name>
      <CanonicalSPDI>NC_000012.12:101753498:TAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="101753499" stop="101753500" display_start="101753499" display_stop="101753500" variantLength="2" positionVCF="101753498" referenceAlleleVCF="TTA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="102147277" stop="102147278" display_start="102147277" display_stop="102147278" variantLength="2" positionVCF="102147276" referenceAlleleVCF="TTA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>AY687932:c.3474_3475delTA</Name>
      </OtherNameList>
      <ProteinChange>H1158fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024312.5" sequenceAccession="NM_024312" sequenceVersion="5" change="c.3474_3475del" MANESelect="true">
            <Expression>NM_024312.5:c.3474_3475del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077288.2" sequenceAccession="NP_077288" sequenceVersion="2" change="p.His1158fs">
            <Expression>NP_077288.2:p.His1158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.102147278_102147279del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.102147278_102147279del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.101753500_101753501del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.101753500_101753501del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021243.1" sequenceAccession="NG_021243" sequenceVersion="1" change="g.82368_82369del">
            <Expression>NG_021243.1:g.82368_82369del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607840.0006" DB="OMIM" />
        <XRef Type="rs" ID="281865038" DB="dbSNP" />
        <XRef ID="CA340013" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024312.5(GNPTAB):c.3474_3475del (p.His1158fs) AND Mucolipidosis type II" Accession="RCV000002894" Version="6">
        <ClassifiedConditionList TraitSetID="711">
          <ClassifiedCondition DB="MedGen" ID="C2673377">Mucolipidosis type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-05-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-05-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-10-01" MostRecentSubmission="2015-04-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16116615</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301730</ID>
          <ID Source="BookShelf">NBK1875</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="711" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3038" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">I cell disease</ElementValue>
                <XRef ID="Mucolipidosis+II/3706" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucolipidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion cell disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leroy Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylglucosamine 1phosphotransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML disorder type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucolipidosis type II</ElementValue>
                <XRef ID="MONDO:0009650" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ML II ALPHA/BETA</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ICD</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ML II</ElementValue>
                <XRef Type="MIM" ID="252500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GNPTA</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis IIIa/ß (ML IIIa/ß), and phenotypes intermediate between ML II and ML IIIa/ß. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML IIIa/ß becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML IIIa/ß are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML IIIa/ß.</Attribute>
                <XRef ID="NBK1828" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6749" />
                <XRef ID="6749" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301728</ID>
                <ID Source="BookShelf">NBK1828</ID>
              </Citation>
              <XRef ID="576" DB="Orphanet" />
              <XRef ID="C2673377" DB="MedGen" />
              <XRef ID="MONDO:0009650" DB="MONDO" />
              <XRef Type="MIM" ID="252500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="91212" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="AY687932:c.3474_3475delTA_NBK1875" title="AY687932:c.3474_3475delTA and Mucolipidosis III Alpha/Beta" />
        <ClinVarAccession Accession="SCV000054683" DateUpdated="2013-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-05-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">AY687932:c.3474_3475delTA</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Mucolipidosis III Alpha/Beta</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1875" />
            <XRef DB="OMIM" ID="252500" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23052" SubmissionDate="2016-07-20" DateLastUpdated="2015-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607840.0006_MUCOLIPIDOSIS II ALPHA/BETA" title="GNPTAB, 2-BP DEL, 3474TA_MUCOLIPIDOSIS II ALPHA/BETA" />
        <ClinVarAccession Accession="SCV000023052" DateUpdated="2015-04-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 2-bp deletion in the GNPTAB gene (3474delTA) that was found in compound heterozygous state in a patient with mucolipidosis II (252500) by Paik et al. (2005), see 607840.0005.</Attribute>
              <Citation>
                <ID Source="PubMed">16116615</ID>
              </Citation>
              <XRef DB="OMIM" ID="252500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNPTAB" />
          </GeneList>
          <Name>GNPTAB, 2-BP DEL, 3474TA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 3474TA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607840.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUCOLIPIDOSIS II ALPHA/BETA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23052" TraitType="Disease" MappingType="Name" MappingValue="MUCOLIPIDOSIS II ALPHA/BETA" MappingRef="Preferred">
        <MedGen CUI="C2673377" Name="Mucolipidosis type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="91212" TraitType="Disease" MappingType="Name" MappingValue="Mucolipidosis III Alpha/Beta" MappingRef="Preferred">
        <MedGen CUI="C0033788" Name="Pseudo-Hurler polydystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

